Harvard Bioscience, Inc. (HBIO) News
Filter HBIO News Items
HBIO News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest HBIO News From Around the Web
Below are the latest news stories about HARVARD BIOSCIENCE INC that investors may wish to consider to help them evaluate HBIO as an investment opportunity.
3 US Penny Stocks With Market Caps Under $100MAs U.S. stocks experience fluctuations amid anticipation of key inflation data and interest rate decisions, investors are keenly observing market movements for potential opportunities. Penny stocks, a term that may seem outdated, continue to capture attention due to their affordability and growth potential, particularly when backed by strong financials. These smaller or newer companies can offer unique value propositions that larger firms might overlook, making them intriguing options for... |
Harvard Bioscience Third Quarter 2024 Earnings: Misses ExpectationsHarvard Bioscience ( NASDAQ:HBIO ) Third Quarter 2024 Results Key Financial Results Revenue: US$22.0m (down 13% from 3Q... |
Harvard Bioscience Inc (HBIO) Q3 2024 Earnings Call Highlights: Navigating Challenges and ...Despite a revenue decline, Harvard Bioscience Inc (HBIO) focuses on innovative products and operational efficiencies to drive future growth. |
3 Promising US Penny Stocks With At Least $100M Market CapAs U.S. stock markets reach record highs following the recent presidential election, investors are keenly exploring diverse opportunities across various sectors. Penny stocks, though often overlooked, represent a niche where smaller or newer companies can offer significant growth potential at lower price points. While the term may seem outdated, these stocks can still be compelling investments when backed by strong financial health and solid fundamentals. |
Harvard Bioscience: Q3 Earnings SnapshotHBIO) on Thursday reported a loss of $4.8 million in its third quarter. The Holliston, Massachusetts-based company said it had a loss of 11 cents per share. Losses, adjusted for one-time gains and costs, came to 2 cents per share. |
Harvard Bioscience Announces Third Quarter 2024 Financial ResultsHOLLISTON, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the third quarter ended September 30, 2024. Jim Green, Chairman and CEO, said, “Our third quarter revenues continued to reflect the effects of the challenging market environment. Our migration to a single US enterprise resource planning system, completed in the third quarter, supports operating efficiencies as well as improvements in inventory and supp |
Is It Too Late To Consider Buying Harvard Bioscience, Inc. (NASDAQ:HBIO)?Harvard Bioscience, Inc. ( NASDAQ:HBIO ), might not be a large cap stock, but it saw significant share price movement... |
Zacks Industry Outlook Highlights Mettler-Toledo International and Harvard BioscienceMettler-Toledo International and Harvard Bioscience are part of the Zacks Industry Outlook article. |
Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ETHOLLISTON, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended September 30, 2024 before the market opens on November 7, 2024, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. Participants who would like to join the call and ask a question must register here. Once registered, you will receive the dial-in numbers and a unique PIN number. Participants who would like to join the a |
Harvard Bioscience Inc (HBIO) Q2 2024 Earnings Call Highlights: Navigating Challenges with ...Despite a revenue dip, Harvard Bioscience Inc (HBIO) focuses on new product launches and cost-saving measures to drive future growth. |